We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+13.79%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.82B
AUM Growth
+$522M
(+12%)
Cap. Flow
+$73.4M
Cap. Flow
% of AUM
1.52%
Top 10 Holdings %
Top 10 Hldgs %
20.44%
Holding
604
New
109
Increased
179
Reduced
173
Closed
43
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$48.8M |
| 2 |
Comcast
CMCSA
|
+$46.9M |
| 3 |
Avery Dennison
AVY
|
+$38.5M |
| 4 |
Middleby
MIDD
|
+$33M |
| 5 |
LKQ Corp
LKQ
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$63.1M |
| 2 |
T. Rowe Price
TROW
|
+$47.7M |
| 3 |
Intuitive Surgical
ISRG
|
+$39M |
| 4 |
Plains All American Pipeline
PAA
|
+$39M |
| 5 |
Sherwin-Williams
SHW
|
+$38.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.65% |
| 2 | Financials | 14.81% |
| 3 | Industrials | 14.31% |
| 4 | Technology | 11.57% |
| 5 | Energy | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Nebius Group N.V.
NBIS
$51.2B
| $7.09M | 0.15% |
194,603
+166,082
| +582% | +$5.46M |
2013 Q2
1 quarter
|
|
102
Targa Resources
TRGP
$60.6B
| $6.87M | 0.14% |
94,098
-41,747
| -31% | -$2.88M |
2013 Q2
1 quarter
|
|
103
ExxonMobil
XOM
$718B
| $6.86M | 0.14% |
79,705
-601
| -0.7% | -$54.2K |
2013 Q2
1 quarter
|
|
|
104
Sherwin-Williams
SHW
$81.8B
| $6.67M | 0.14% |
109,845
-656,034
| -86% | -$38.5M |
2013 Q2
1 quarter
|
|
105
IBM
IBM
$221B
| $6.57M | 0.14% |
37,093
-1,274
| -3% | -$232K |
2013 Q2
1 quarter
|
|
106
Biogen
BIIB
$34.8B
| $6.56M | 0.14% |
27,265
+14,440
| +113% | +$3.23M |
2013 Q2
1 quarter
|
|
107
Genesis Energy
GEL
$1.7B
| $6.53M | 0.14% |
130,420
+3,780
| +3% | +$190K |
2013 Q2
1 quarter
|
|
108
Grifois
GRFS
$5.13B
| $6.5M | 0.14% |
429,620
+111,884
| +35% | +$1.74M |
2013 Q2
1 quarter
|
|
|
WFM
109
DELISTED
Whole Foods Market Inc
WFM
| $6.45M | 0.13% |
110,199
-93,599
| -46% | -$5.17M |
2013 Q2
1 quarter
|
|
110
DELISTED
ARM HOLDINGS PLC ADS
ARMH
| $6.34M | 0.13% |
131,700
-101,997
| -44% | -$4.31M |
2013 Q2
1 quarter
|
|
|
CBI
111
DELISTED
Chicago Bridge & Iron Nv
CBI
| $5.75M | 0.12% |
84,806
+29,591
| +54% | +$1.83M |
2013 Q2
1 quarter
|
|
112
Johnson & Johnson
JNJ
$610B
| $5.35M | 0.11% |
61,745
-3,737
| -6% | -$335K |
2013 Q2
1 quarter
|
|
113
Enbridge
ENB
$104B
| $5.28M | 0.11% |
126,381
-81,982
| -39% | -$3.49M |
2013 Q2
1 quarter
|
|
114
GE Aerospace
GE
$324B
| $5.05M | 0.1% |
44,146
+2,958
| +7% | +$339K |
2013 Q2
1 quarter
|
|
115
SPDR Gold Trust
GLD
$142B
| $4.94M | 0.1% |
38,561
-626
| -2% | -$80.4K |
2013 Q2
1 quarter
|
|
116
Canadian National Railway
CNI
$72.9B
| $4.72M | 0.1% |
93,072
+13,294
| +17% | +$656K |
2013 Q2
1 quarter
|
|
117
McDonald's
MCD
$172B
| $4.71M | 0.1% |
48,995
-197,215
| -80% | -$19.3M |
2013 Q2
1 quarter
|
|
118
Berkshire Hathaway Class B
BRK.B
$1.13T
| $4.67M | 0.1% |
41,159
+7,364
| +22% | +$850K |
2013 Q2
1 quarter
|
|
119
Procter & Gamble
PG
$365B
| $4.46M | 0.09% |
58,976
-3,489
| -6% | -$278K |
2013 Q2
1 quarter
|
|
|
NGLS
120
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
| $4.37M | 0.09% |
84,800
+3,720
| +5% | +$187K |
2013 Q2
1 quarter
|
|
121
JPMorgan Chase
JPM
$891B
| $4.23M | 0.09% |
81,866
+2,427
| +3% | +$130K |
2013 Q2
1 quarter
|
|
122
Brookfield Infrastructure Partners
BIP
$17.1B
| $4.2M | 0.09% |
278,634
-936,288
| -77% | -$13.6M |
2013 Q2
1 quarter
|
|
123
Evertec
EVTC
$1.88B
| $4.14M | 0.09% |
186,615
+58,244
| +45% | +$1.39M |
2013 Q2
1 quarter
|
|
124
Caesarstone
CSTE
$93.4M
| $4.07M | 0.08% |
89,111
+25,372
| +40% | +$960K |
2013 Q2
1 quarter
|
|
|
MWIV
125
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
| $4.04M | 0.08% |
27,015
+3,265
| +14% | +$462K |
2013 Q2
1 quarter
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Geneva Advisors held 604 positions worth $4.82B, up 12% from $4.3B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Geneva Advisors's Q3 2013 filing shows 109 new, 179 increased, 173 reduced and 43 closed positions. Its largest new stake was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M. The largest sale was Monsanto Co, an estimated $63.1M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
- Geneva Advisors's largest Q3 2013 buy was Regeneron Pharmaceuticals: 185,591 shares worth $58.1M.
- Geneva Advisors added most to Comcast in Q3 2013, an estimated $46.9M increase.
- Geneva Advisors's biggest Q3 2013 reduction was Monsanto Co, cutting an estimated $63.1M.
- Geneva Advisors fully exited Valmont Industries in Q3 2013, selling an estimated $36.7M.
- Geneva Advisors's ten largest holdings make up 20% of its $4.82B portfolio in Q3 2013.
- Geneva Advisors opened 109 new positions and closed 43 in Q3 2013.
- Geneva Advisors's portfolio value rose 12% quarter-over-quarter to $4.82B.
Based on Geneva Advisors's 13F filing for Q3 2013, filed 4 Nov 2013.